glp 1 analogues side effects Relative of glucagon-like peptide-1 (GLP-1) agonists vs How to Avoid the Side

A clinician trained in midlife health can help you figure out if one of these meds would be a good fit for you

Patel says the retatrutide discussion should serve as a reminder that ongoing patient-doctor communication is vital with any weight loss drug

SURMOUNT-1: Tirzepatide 15 mg, the generational leap of 2022 SURMOUNT-1 (Jastreboff et al., NEJM 2022, PMID 35658024) randomized 2,539 obese adults without diabetes to tirzepatide 5, 10, or 15 mg/week or placebo over 72 weeks

This targeted insulinogenic action helps maintain postprandial blood glucose levels within a normal range

Back Hoet, JP (1953) 'Gustave Eduoard Laguesse: His demonstration of the significance of the Islands of Langerhans', Diabetes , 2,4, 322-24

Results are expected in December 2026